Why the study?
Coronary microvascular disease remains a major clinical challenge due to limited mechanistic understanding and difficult diagnosis, prompting evaluation of targeted active factor XIII imaging for detecting thrombus-associated disease.
Does molecular imaging of active factor XIII (FXIII) detect early onset coronary microvascular disease in a mouse model?
Does molecular imaging of active factor XIII (FXIII) detect early onset coronary microvascular disease in a mouse model?
Molecular imaging of active factor XIII using a targeted radiolabeled probe may serve as a biomarker for early detection of coronary microvascular disease associated with microthrombi in a mouse model.
FXIII-targeted imaging detects microvascular thrombi in animals; leaves open clinical translation for coronary MVD diagnosis.
Coronary microvascular disease (MVD) remains a major clinical problem due to limited mechanistic understanding and a challenging diagnosis. In the present study we evaluated the utility of targeted imaging of active factor XIII (FXIII) for detection of coronary MVD associated with thrombus. We hypothesized that a high specificity and sensitivity FXIII targeted radiolabeled probe can serve as a biomarker for cross-linked thrombi in the microvasculature, and thus an indicator for underlying coronary MVD. To evaluate this approach, a coronary MVD model was established for local induction of singlet oxygen and reactive oxygen species (ROS) via a photochemical reaction (PCR). Methods: PCR was used to induce endothelial injury and microthrombi via focal over-production of ROS only in the coronary microvasculature. Oxidative stress was initially evaluated in primary coronary endothelial cells to optimize parameters of PCR, which were then translated to in vivo experiments. To develop the coronary MVD model, 64 mice were assigned to one of four groups after thoracotomy: 1) sham control; 2) rose bengal; 3) green light; or 4) their combination. Following interventions, the mice underwent transmission electron microscopy, fluorescent myocardial perfusion, coronary angiography, and immunohistochemical staining. Echocardiography (n = 12) and gene expression (n = 10) studies were also performed after MVD induction to monitor serial changes in cardiac function and explore possible mechanisms. To diagnose early onset MVD, FXIII radioactivity was assessed in 104 mice using ex vivo gamma well counting (GWC) and in 14 mice using in vivo serial single photon emission computed tomography / computed tomography (SPECT/CT) imaging of a FXIII targeted technetium-labeled probe ( 99m Tc-NC100668).
No takes yet. Share an insight, caveat, or question.
Zhuang et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: